FDA 483 - ChemRite CoPac, Inc. - July 20, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
ChemRite CoPac, Inc. in Lannon, WI, a drug product manufacturer, was cited with six observations during an FDA inspection. The inspection revealed significant deficiencies in quality unit staffing, laboratory controls for water sampling and testing, equipment maintenance, and the thoroughness of complaint investigations. Furthermore, the firm failed to establish and follow appropriate written procedures for preventing objectionable microorganisms and for equipment cleaning and maintenance.
ID · e0901e0b-ebf1-41f1-8a15-d7af3a8bfe5d